Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811401) titled 'Lemborexant on Perioperative Sleep Quality in Patients Undergoing Thoracoscopic Surgery' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Beijing Tiantan Hospital

Condition: Postoperative Sleep Disturbance Thoracoscopic Surgery

Intervention: Drug: Lemborexant 5 mg

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 8, 2026

Target Sample Size: 130

To know more, visit https://cli...